Navigation Links
Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors

om/> .

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:

This release contains forward-looking statements, including summary statements relating to interim or preliminary results of clinical trials involving oral azacitidine. Such statements are based on current expectations and involve a number of known and unknown risks and uncertainties that could cause the final results to differ significantly from the results summarized by such statements. Some of the clinical trials described in this release are being conducted by independent investigators and Pharmion does not control and cannot predict the final results of those trials. Top line or preliminary results may not be confirmed upon full analysis of the detailed results of a trial and additional information relating to the safety, efficacy or tolerability of oral azacitidine may be discovered upon further analysis of clinical trial data and upon review and analysis of data from other clinical trials. Additional risks and uncertainties relating to Pharmion and its business can be found in the "Risk Factors" section of Pharmion's Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2007, its Annual Report on Form 10-K for the year ended December 31, 2006 and in Pharmion's other filings with the U.S. Securities and Exchange Commission. Forward-looking statements speak only as of the date on which they are made, and Pharmion undertakes no obligation to update publicly or revise any forward-looking statement, whether as a result of new information, future developments or otherwise. Pharmion also disclaims any duty to comment upon or correct information that may be contained in reports published by the investment community.

# # #

------------------

(Back to top)

Exelixis Reports Comprehensive XL880 Phase I Data At ASCO

-Results support ongoing Phase II clinical development program-

CHICAGO, June 2 /PRNewswire-Fi
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
Post Your Comments:
(Date:3/2/2015)... Diabetes Care, American Association of Diabetes Educators, ... Asante Solutions, A. Menarini, Bayer Group, Bayer ... Centres for Medicare and Medicaid Services ( ... Control and Prevention (CDC), Carlyle Group, Cascade ... Covidien, Cygnus, ConvaTec, Constitution Medical Investor, Dexcom, ...
(Date:3/1/2015)... /CNW Telbec/ -   Ergoresearch Ltd (TSXV: ERG) – ... under the « Équilibre, orthèses et biomécanique» banner ... on December 31, 2014. All dollar amounts in the ... Revenues for the second quarter of fiscal year 2015 ... by 8,8 % compared to revenues of $ 4 489 ...
(Date:3/1/2015)... ATLANTA , March 1, 2015  Patients ... new weapon against this debilitating foot ailment, according ... Interventional Radiology ,s Annual Scientific Meeting . ... to penetrate, emulsify and remove diseased fasciitis tissue. ... healthy tissue to regrow in its place, restoring ...
Breaking Medicine Technology:Blood Glucose Meters Industry 2019 Forecasts for Global and Chinese Regions 2Second Quarter results - Fiscal 2015 - Ergoresearch reports its results for the quarter ended December 31, 2014. 2Second Quarter results - Fiscal 2015 - Ergoresearch reports its results for the quarter ended December 31, 2014. 3Second Quarter results - Fiscal 2015 - Ergoresearch reports its results for the quarter ended December 31, 2014. 4Interventional radiology treatment relieves chronic plantar fasciitis 2Interventional radiology treatment relieves chronic plantar fasciitis 3
... Dynatronics Corporation (Nasdaq: DYNT ) announced ... RB Milestone Portfolio, a group of companies selected by ... the market via a combination of traditional and innovative ... Network™, and non-deal roadshows, with a focus on the ...
... 16, 2011 McGraw-Hill Professional, a leading ... scientific and medical communities, and Simbionix™, the ... simulation technology, have partnered to bring surgical ... training resource AccessSurgery™ ( www.accesssurgery.com ) to ...
Cached Medicine Technology:Dynatronics Selected for Inclusion in RB Milestone Portfolio 2McGraw-Hill Professional and Simbionix™ Partner to Provide Enhanced Surgical Simulation and Education 2
(Date:3/1/2015)... Comparing a new source of vehicle ... Quotes Pros portal this year. A broad range of ... that are being supplied through the finder at ... prices available for each policy is now provided in ... user will first be asked to present their unique ...
(Date:3/1/2015)... March 01, 2015 A federal ... http://www.consumerinjurylawyers.com/wright-profemur-hip-replacement ) scheduled to go to trial in ... a witness to provide testimony regarding the role ... of the Profemur device, Bernstein Liebhard LLP comments. ... Court, Northern District of Iowa on February 25th, ...
(Date:3/1/2015)... 01, 2015 Indiana Fiber Network, ... Provider, announces NewWays Networking, LLC (NewWays) selected IFN ... with IFN, NewWays is well positioned to scale ... for Internet bandwidth in rural parts of Indiana,” ... to Cory Childs IFN Enterprise Sales Manager, IFN ...
(Date:3/1/2015)... California (PRWEB) March 01, 2015 Theme ... a new transition pack for Final Cut ... add accordion style transitions to any FCPX editors project.” ... given our users the tools needed to easily drag ... , The user gets many different controls over the ...
(Date:2/28/2015)... February 28, 2015 In recent years Medical ... of practicing physicians as a way for them to expand ... regarding Cannabis as medicine. Since the FDA still lists Cannabis ... resources available to licensed physicians that can help guide ... Dr. Deborah Malka in Santa Cruz, CA is a ...
Breaking Medicine News(10 mins):Health News:United Auto Insurance Rates Now Quoted at Consumer Insurance Portal Online 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 3Health News:NewWays Networking Selects Indiana Fiber Network, LLC as Fiber Transport Provider 2Health News:Announcing a New Transition Pack from Pixel Film Studios, Transccordion for Final Cut Pro X 2Health News:Reputable Cannabis Doctor In Santa Cruz and Monterey Joins the Medical Cannabis Network 2
... in Canada,s north, Canada would benefit from enhanced relationships ... CMAJ ( Canadian Medical Association Journal ) ... looks at health and health care in Canada,s north ... includes Alaska in the US, Norway, Sweden, Finland, Russia, ...
... was diagnosed in 2007 with acute multiple myeloma, a form ... troubles all those who receive an upsetting diagnosis. The way ... however, was different. Barrager drew upon his engineering and management ... is sharing his insights with hospitals and doctors in his ...
... Reporter , MONDAY, Nov. 1 (HealthDay News) -- Pain is a ... reports of pain increasing during the final few months, a new ... being "troubled" by moderate or severe pain two years before they ... had jumped to nearly half. "This study shows that ...
... , MONDAY, Nov. 1 (HealthDay News) -- The success ... fat (MUFA), which are commonly found in nuts, seeds, avocados, ... oil, new research suggests. In the study, researchers randomly ... moderate elevated cholesterol levels to either a high-MUFA diet or ...
... , MONDAY, Nov. 1 (HealthDay News) -- Stroke ... the hospital on the weekend instead of a weekday, regardless ... Canadian researchers analyzed data from almost 21,000 stroke patients ... Only patients with their first stroke were included in the ...
... National Jewish Health has received a US patent for ... help assure many patients that dramatic changes in lifestyle ... PhD, Medical Director of the Advanced Diagnostic Laboratories at ... Donald MacGlashan, Jr. developed the diagnostic assay, which makes ...
Cached Medicine News:Health News:Management science guru, surviving cancer, offers hope to fellow sufferers, doctors 2Health News:Management science guru, surviving cancer, offers hope to fellow sufferers, doctors 3Health News:Almost Half of Elderly Report Pain in Life's Final Months 2Health News:Almost Half of Elderly Report Pain in Life's Final Months 3Health News:Adding Monounsaturated Fats to Diet May Boost Heart Health 2Health News:Weekend Admissions Worse for Stroke Victims: Study 2Health News:National Jewish Health receives patent for diagnostic method of autoimmune chronic urticaria 2
Sterile perfluorocarbon for intraocular Application....
Silikon 1000 (purified polydimethylsiloxane) is a highly purified long chain polydimethylsiloxane trimethylsiloxy terminated silicone oil. For use as a postoperative retinal tamponade during vitreore...
... hard contact lens cleaning solution ... use, and professionally proven cleaner. ... detergents resulting in a very ... deposits, cosmetic residue, salts, mucous ...
4.625 inches, curved blade 4 mm....
Medicine Products: